Clinical trial
Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Patients With Squamous Cell Carcinoma of the Oropharynx, Larynx or Hypopharynx With a Clinically Negative Neck: (Chemo)Radiotherapy to the PRIMary Tumor Only. The PRIMO Study.
NCT05333523 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Patients With Squamous Cell Carcinoma of the Oropharynx, Larynx or Hypopharynx With a Clinically Negative Neck: (Chemo)Radiotherapy to the PRIMary Tumor Only. The PRIMO Study.
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- December 6, 2023
- Completion date
- December 1, 2029
- Enrollment
- 242 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
hypopharynx squamous cell carcinoma, laryngeal squamous cell carcinoma, oropharyngeal squamous cell carcinoma